ABE-IPSABE HOLDINGABE BOOKS
English Polski
On-line access

Bookstore

0.00 PLN
Bookshelf (0) 
Your bookshelf is empty
Fast Facts: Biosimilars in Hematology and Oncology: Biologics and biosimilars - getting decisions right

Fast Facts: Biosimilars in Hematology and Oncology: Biologics and biosimilars - getting decisions right

Authors
Publisher Karger
Year 2020
Pages 128
Version paperback
Language English
ISBN 9781912776214
Categories Chemotherapy
Delivery to United States

check shipping prices
Ask about the product
Email
question
  Send
Add to bookshelf

Book description

Biologics have revolutionized - and are revolutionizing - the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars - particularly in curative cancer treatment, where they are relatively recent therapeutic options. 'Fast Facts: Biosimilars in Hematology and Oncology' provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients. Contents: - Biologics and the need for biosimilars - Why do we need biosimilars? - How is the quality of biosimilar medicines assured? - Legal issues - Switching, interchangeability and extrapolation - Safety and pharmacovigilant - Global issues - Formulary considerations: pharmacy issues - Formulary considerations: supportive care biosimilars - Formulary considerations: therapeutic anti-cancer biosimilars - Communication and awareness

Fast Facts: Biosimilars in Hematology and Oncology: Biologics and biosimilars - getting decisions right

We also recommend books

Strony www Białystok Warszawa
801 777 223